We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Microscopy Innovation Developed to Diagnose Cancer

By LabMedica International staff writers
Posted on 23 May 2017
Researchers have developed a spectrophotometric technique for microscopic analysis of variations in single cancer cells, enabling more efficient diagnosis of melanomas, including metastasize forms.

For years, melanoma researchers have studied samples that were considered uniform in size and color. More...
But melanomas don’t always come in the same shape and hue; often, melanomas are irregular and dark, making them difficult to investigate.

“Researchers often seek out the types of cancerous cells that are homogenous in nature and are easier to observe with traditional microscopic devices,” said study first author Luis Polo-Parada, associate professor at University of Missouri, “Yet, because the vast amount of research is conducted on one type of cell, it often can lead to misdiagnosis in a clinical setting.”

In their new study, including researchers in Mexico as part of UM’s “Mizzou Advantage” program to foster interdisciplinary collaboration, the team devised a tool to detect and analyze single melanoma cells that are more representative of the skin cancers developed by most patients. They decided to supplement the emerging technique photoacoustic (PA) spectroscopy, a specialized optical technique used to probe tissues and cells non-invasively. Ellison Gordon of UM’s machine shop was involved in the manufacturing of components for the microscope setup.

Current systems use the formation of sound waves followed by the absorption of light, so the tissues must adequately absorb the laser light. This is why most researchers have focused only on consistently hued and shaped melanoma cells. The team modified a microscope that was able to merge light sources at a range conducive to observing the details of single melanoma cells. Using the modified system, they could identify irregularities in human melanoma and breast cancers as well as mouse melanoma cells, enabling them to reach a diagnosis with greater ease and efficiency. The team also noted that as the cancer cells divided, they grew paler in color yet the system was able to detect the newer, smaller cells as well.

“Overall, our studies show that by using modified techniques we will be able to observe non-uniform cancer cells, regardless of their origin,” Prof. Polo-Parada said, “Additionally, as these melanoma cells divide and distribute themselves throughout the blood, they can cause melanomas to metastasize. We were able to observe those cancers as well. This method could help medical doctors and pathologists to detect cancers as they spread, becoming one of the tools in the fight against this fatal disease.”

The study, by Polo-Parada L et al, was published March 13, 2017, in the journal Analyst.


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
PlGF Test
Quidel Triage PlGF Test
New
Automated Microscope
dIFine
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.